Insilico Medicine
Insilico Medicine is a drug discovery, artificial intelligence company that looks to treat cancer and age related diseases
6
Funding Rounds
$356.3m
Money raised
Overview
Insilico Medicine is a drug discovery, artificial intelligence company that looks to treat cancer and age related diseases
-
Websites:
- Business model: B2B
- Headquarters: Hong Kong
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Al** Zh**** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Insilico Medicine has raised a total of $352m in funding over 6 rounds.
Key Insights:
- Insilico Medicine Series D round, June 2022: $60m
- Insilico Medicine Series C round, June 2021: $255m
- Insilico Medicine funding round, September 2019: $37m
- Insilico Medicine Series A round, February 2017: $2.8m
- Insilico Medicine Convertible note, November 2014: $1.2m
- Insilico Medicine Seed round, April 2014: $300k
Insilico Medicine Series D round, June 2022
$60m
Insilico Medicine Series C round, June 2021
$255m
Insilico Medicine funding round, September 2019
$37m
Insilico Medicine Series A round, February 2017
$2.8m
Insilico Medicine Convertible note, November 2014
$1.2m
Insilico Medicine Seed round, April 2014
$300k
Industries
Insilico Medicine is active in the following industries: